مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.
Normal view MARC view ISBD view

Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. [electronic resource]

By:
  • Iyevleva, Aglaya G
Contributor(s):
  • Mitiushkina, Natalia V
  • Karaseva, Nina A
  • Orlov, Sergey V
  • Volodina, Larisa N
  • Kulikova, Yulia E
  • Lozhkina, Alexandra M
  • Ivantsov, Alexandr O
  • Tiurin, Vladislav I
  • Togo, Alexandr V
  • Imyanitov, Evgeny N
Producer: 20150120Description: e31-3 p. digitalISSN:
  • 1556-1380
Subject(s):
  • Adenocarcinoma -- drug therapy
  • Amino Acid Sequence
  • Base Sequence
  • Carcinoma, Large Cell -- drug therapy
  • Carcinoma, Squamous Cell -- drug therapy
  • ErbB Receptors -- antagonists & inhibitors
  • Exons -- genetics
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms -- drug therapy
  • Middle Aged
  • Molecular Sequence Data
  • Mutagenesis, Insertional -- genetics
  • Neoplasm Staging
  • Prognosis
  • Protein Kinase Inhibitors -- therapeutic use
  • Quinazolines -- therapeutic use
Online resources:
  • Available from publisher's website
In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 9
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.

Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.

APA

Iyevleva A. G., Mitiushkina N. V., Karaseva N. A., Orlov S. V., Volodina L. N., Kulikova Y. E., Lozhkina A. M., Ivantsov A. O., Tiurin V. I., Togo A. V. & Imyanitov E. N. (20150120). Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Iyevleva Aglaya G, Mitiushkina Natalia V, Karaseva Nina A, Orlov Sergey V, Volodina Larisa N, Kulikova Yulia E, Lozhkina Alexandra M, Ivantsov Alexandr O, Tiurin Vladislav I, Togo Alexandr V and Imyanitov Evgeny N. 20150120. Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Iyevleva A. G., Mitiushkina N. V., Karaseva N. A., Orlov S. V., Volodina L. N., Kulikova Y. E., Lozhkina A. M., Ivantsov A. O., Tiurin V. I., Togo A. V. and Imyanitov E. N. (20150120). Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Iyevleva Aglaya G, Mitiushkina Natalia V, Karaseva Nina A, Orlov Sergey V, Volodina Larisa N, Kulikova Yulia E, Lozhkina Alexandra M, Ivantsov Alexandr O, Tiurin Vladislav I, Togo Alexandr V and Imyanitov Evgeny N. Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20150120.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site